Get the Stockscreener App
90.60
1.45%
-1.33
Ani Pharmaceuticals Inc stock is traded at $90.60, with a volume of 324.42K.
It is down -1.45% in the last 24 hours and down -1.09% over the past month.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
See More
Previous Close:
$91.93
Open:
$92.25
24h Volume:
324.42K
Relative Volume:
0.69
Market Cap:
$1.97B
Revenue:
$747.40M
Net Income/Loss:
$-12.60M
P/E Ratio:
-117.86
EPS:
-0.7687
Net Cash Flow:
$105.18M
1W Performance:
-3.86%
1M Performance:
-1.09%
6M Performance:
+27.93%
1Y Performance:
+58.27%
1-Day Range:
$90.45
$94.00
1-Week Range:
$90.06
$96.57
52-Week Range:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Name
Ani Pharmaceuticals Inc
Sector
Phone
(218) 634-3500
Address
210 MAIN STREET WEST, BAUDETTE, MN
Compare ANIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
90.60 | 2.05B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Initiated | H.C. Wainwright | Buy |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Mar-12-25 | Initiated | JP Morgan | Overweight |
| Dec-11-24 | Initiated | Leerink Partners | Outperform |
| Oct-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-15-24 | Initiated | CapitalOne | Overweight |
| Aug-22-23 | Reiterated | H.C. Wainwright | Buy |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Sep-07-22 | Initiated | H.C. Wainwright | Buy |
| Nov-02-21 | Initiated | Truist | Buy |
| May-07-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| May-10-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-16-17 | Reiterated | Canaccord Genuity | Buy |
| Jul-31-17 | Initiated | Canaccord Genuity | Buy |
| Feb-22-17 | Downgrade | ROTH Capital | Buy → Neutral |
| Jun-23-16 | Initiated | Raymond James | Strong Buy |
| May-24-16 | Downgrade | Standpoint Research | Buy → Hold |
| Nov-13-15 | Initiated | Standpoint Research | Buy |
| Sep-28-15 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-05-15 | Reiterated | Oppenheimer | Outperform |
| Aug-04-15 | Reiterated | ROTH Capital | Neutral |
| Jul-31-15 | Reiterated | Oppenheimer | Outperform |
| Jul-15-15 | Reiterated | ROTH Capital | Neutral |
| Jun-23-15 | Reiterated | Oppenheimer | Outperform |
| May-18-15 | Reiterated | ROTH Capital | Neutral |
| May-06-15 | Reiterated | Oppenheimer | Outperform |
| Apr-10-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-26-15 | Reiterated | ROTH Capital | Buy |
| Feb-18-15 | Reiterated | Oppenheimer | Outperform |
View All
Ani Pharmaceuticals Inc Stock (ANIP) Latest News
Using flow based indicators on ANI Pharmaceuticals Inc.Weekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Predicting ANI Pharmaceuticals Inc. trend using moving averagesWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
What indicators show strength in ANI Pharmaceuticals Inc.Market Movers & Real-Time Buy Zone Alerts - newser.com
Smart tools for monitoring ANI Pharmaceuticals Inc.’s price action2025 Market Outlook & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-10-31 04:42:45 - newser.com
Published on: 2025-10-31 04:40:15 - newser.com
How ANI Pharmaceuticals Inc. stock trades during market volatility2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
Can ANI Pharmaceuticals Inc. stock continue upward trendJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
Published on: 2025-10-31 02:28:58 - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy callWeekly Earnings Recap & Fast Exit/Entry Strategy Plans - newser.com
Regression analysis insights on ANI Pharmaceuticals Inc. performanceWeekly Market Report & Safe Entry Point Alerts - newser.com
ANI Pharmaceuticals (ANIP) to Release Earnings on Friday - MarketBeat
Will ANI Pharmaceuticals Inc. (BSFA) stock boost dividends furtherJuly 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
Applying Elliott Wave Theory to ANI Pharmaceuticals Inc.2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com
Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsWeekly Stock Recap & Real-Time Volume Surge Alerts - newser.com
ANI Pharmaceuticals, Inc. (ANIP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Reversal indicators forming on ANI Pharmaceuticals Inc. stockExit Point & Intraday High Probability Setup Alerts - newser.com
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Teacher Retirement System of Texas - MarketBeat
Why ANI Pharmaceuticals Inc. stock could rally in 2025CEO Change & Verified Technical Signals - newser.com
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
ANI Pharma wins Overweight rating at J.P. Morgan on growth prospects - MSN
Mizuho Markets Americas LLC Buys 15,357 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What high frequency data says about ANI Pharmaceuticals Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com
ANI Pharmaceuticals Inc Stock Analysis and ForecastMarket Rumors and News & Trade Like a Pro Using AI Edge - earlytimes.in
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha
What dividend safety score for ANI Pharmaceuticals Inc. stockTrade Performance Summary & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Will ANI Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Weekly High Potential Stock Alerts - Fundação Cultural do Pará
Will ANI Pharmaceuticals Inc. stock maintain growth storyJuly 2025 PostEarnings & High Win Rate Trade Tips - Fundação Cultural do Pará
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards? - Nasdaq
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Published on: 2025-10-26 17:36:11 - newser.com
Published on: 2025-10-26 16:54:24 - newser.com
ANI Pharmaceuticals Q1 2025 Earnings Preview - MSN
Ani Pharmaceuticals Inc Stock (ANIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):